Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.710
 Why?
Cancer Vaccines
13
2022
80
2.540
 Why?
Peptides
17
2022
220
2.480
 Why?
Carbohydrates
14
2009
39
2.290
 Why?
Molecular Mimicry
13
2007
38
1.940
 Why?
Breast Neoplasms
12
2024
1198
1.670
 Why?
Neoplasms
9
2022
1248
1.450
 Why?
Immunotherapy
6
2022
234
1.070
 Why?
Epitopes, T-Lymphocyte
6
2009
26
0.870
 Why?
HIV Envelope Protein gp120
4
2009
9
0.810
 Why?
Lung Neoplasms
4
2014
597
0.810
 Why?
HIV-1
4
2009
50
0.790
 Why?
Antibodies, Neoplasm
2
2017
28
0.780
 Why?
Mice, Inbred BALB C
16
2011
293
0.770
 Why?
Antigens
4
2003
41
0.740
 Why?
Animals
31
2023
13063
0.650
 Why?
Epithelial-Mesenchymal Transition
2
2020
51
0.630
 Why?
Clinical Trials, Phase I as Topic
2
2017
25
0.610
 Why?
Gene Expression Regulation, Neoplastic
5
2020
831
0.600
 Why?
Vaccines, DNA
6
2006
12
0.590
 Why?
Immunologic Surveillance
2
2009
11
0.590
 Why?
HIV Antigens
3
2006
9
0.570
 Why?
Epitopes
3
2009
60
0.550
 Why?
Cell Transformation, Neoplastic
1
2018
182
0.550
 Why?
Antineoplastic Agents
3
2017
1165
0.530
 Why?
Immunity, Innate
3
2018
104
0.520
 Why?
Neoplasm Proteins
1
2018
320
0.500
 Why?
Molecular Targeted Therapy
1
2017
122
0.500
 Why?
Mice
20
2011
5659
0.500
 Why?
Epigenesis, Genetic
1
2018
371
0.470
 Why?
Cell Hypoxia
1
2015
82
0.460
 Why?
Biomimetic Materials
1
2014
10
0.460
 Why?
Estrogen Receptor alpha
1
2015
90
0.460
 Why?
Vaccines
4
2002
50
0.440
 Why?
T-Lymphocytes
7
2010
325
0.430
 Why?
Cross Reactions
8
2006
40
0.420
 Why?
Oligosaccharides
4
2007
34
0.420
 Why?
Amino Acid Sequence
9
2006
575
0.420
 Why?
Molecular Sequence Data
9
2006
760
0.420
 Why?
Sarcoma, Experimental
2
2004
13
0.410
 Why?
Humans
35
2024
50419
0.410
 Why?
Antigens, Neoplasm
5
2007
148
0.410
 Why?
Polysaccharides
2
2011
51
0.410
 Why?
AIDS Vaccines
3
2009
8
0.390
 Why?
Isoflavones
1
2023
89
0.390
 Why?
Plant Lectins
2
2010
8
0.390
 Why?
Sulfotransferases
3
2020
39
0.370
 Why?
Chondroitin Sulfates
2
2011
13
0.370
 Why?
Soybean Proteins
1
2023
161
0.360
 Why?
P-Selectin
2
2011
31
0.360
 Why?
CD8-Positive T-Lymphocytes
3
2007
127
0.350
 Why?
Autoantigens
1
2011
49
0.350
 Why?
Fructose
1
2010
22
0.350
 Why?
Carbon
1
2010
54
0.340
 Why?
Adaptive Immunity
1
2010
32
0.340
 Why?
CD4-Positive T-Lymphocytes
3
2006
158
0.320
 Why?
Vaccines, Subunit
3
2006
14
0.320
 Why?
Obesity
2
2023
1123
0.320
 Why?
Drug Delivery Systems
1
2010
143
0.300
 Why?
Carcinoma, Ductal
1
2008
7
0.300
 Why?
Proteoglycans
3
2023
81
0.290
 Why?
Mammary Neoplasms, Experimental
2
2005
121
0.290
 Why?
Interferon-gamma
4
2018
175
0.280
 Why?
Carcinoma in Situ
1
2008
73
0.280
 Why?
Cell Line, Tumor
6
2011
1393
0.280
 Why?
Dendritic Cells
3
2005
135
0.270
 Why?
Female
18
2024
27053
0.270
 Why?
T-Lymphocytes, Cytotoxic
5
2009
63
0.270
 Why?
Concanavalin A
2
2005
15
0.250
 Why?
HIV Infections
1
2009
347
0.240
 Why?
Sarcoma
1
2006
65
0.240
 Why?
Mammary Neoplasms, Animal
1
2005
35
0.240
 Why?
Ligands
5
2011
203
0.230
 Why?
MCF-7 Cells
4
2020
62
0.230
 Why?
Neoplasm Metastasis
5
2015
230
0.230
 Why?
Magnetic Resonance Spectroscopy
1
2005
242
0.230
 Why?
Acetylglucosamine
1
2004
6
0.220
 Why?
Histocompatibility Antigens Class I
1
2004
46
0.220
 Why?
Combined Modality Therapy
2
2017
640
0.220
 Why?
Melanoma
1
2007
278
0.210
 Why?
Immunoglobulin G
2
2003
188
0.210
 Why?
Immunotherapy, Active
1
2003
4
0.210
 Why?
Peptide Fragments
1
2004
208
0.210
 Why?
Peptide Library
4
2005
16
0.200
 Why?
Autoantibodies
2
2018
114
0.200
 Why?
Cell Proliferation
4
2020
980
0.200
 Why?
Glycosylation
3
2010
103
0.200
 Why?
Antigens, Viral
1
2002
42
0.190
 Why?
Apoptosis
2
2020
1092
0.190
 Why?
Antibodies, Monoclonal
5
2023
460
0.190
 Why?
Liver Neoplasms
1
2005
321
0.180
 Why?
Biochemistry
1
2001
5
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
227
0.180
 Why?
Cell Adhesion
3
2006
155
0.170
 Why?
CHO Cells
3
2006
117
0.170
 Why?
Carbamates
1
2020
16
0.170
 Why?
Cricetinae
3
2006
207
0.170
 Why?
Adjuvants, Immunologic
2
2014
52
0.170
 Why?
Colchicine
1
2020
24
0.170
 Why?
Antineoplastic Agents, Phytogenic
1
2020
66
0.160
 Why?
Carcinoma, Ductal, Breast
1
2020
90
0.160
 Why?
Neoplastic Stem Cells
1
2020
97
0.160
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
82
0.160
 Why?
Tumor Microenvironment
2
2024
221
0.150
 Why?
Anthroposophy
1
2018
1
0.150
 Why?
Tumor Cells, Cultured
3
2015
453
0.150
 Why?
Antibody Formation
3
2003
50
0.150
 Why?
Cell Division
3
2006
292
0.150
 Why?
Gene-Environment Interaction
1
2018
36
0.150
 Why?
Immunization
3
2004
61
0.150
 Why?
Immune Tolerance
2
2009
83
0.140
 Why?
Plant Extracts
1
2020
174
0.140
 Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.140
 Why?
Flow Cytometry
3
2006
472
0.140
 Why?
Cell Movement
4
2020
244
0.140
 Why?
Spleen
3
2004
169
0.140
 Why?
Homeostasis
1
2018
203
0.140
 Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.130
 Why?
Forecasting
1
2017
144
0.130
 Why?
HIV Antibodies
2
2006
9
0.130
 Why?
Models, Immunological
2
2007
7
0.120
 Why?
Membrane Proteins
2
2023
337
0.120
 Why?
Phenotype
2
2010
736
0.120
 Why?
Interleukin-12
2
2006
29
0.120
 Why?
Lectins
2
2006
14
0.120
 Why?
Coculture Techniques
1
2015
140
0.120
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
57
0.120
 Why?
Drug Therapy
1
2014
46
0.110
 Why?
Transforming Growth Factor beta
1
2015
134
0.110
 Why?
Antibodies
1
2014
151
0.110
 Why?
Adipocytes
1
2015
126
0.110
 Why?
Nuclear Proteins
1
2015
235
0.110
 Why?
Vaccines, Conjugate
2
2005
9
0.110
 Why?
Cell Separation
2
2005
92
0.100
 Why?
Scavenger Receptors, Class E
1
2015
203
0.100
 Why?
Rats, Zucker
1
2023
67
0.100
 Why?
Positron-Emission Tomography
1
2014
290
0.100
 Why?
Cytotoxicity, Immunologic
2
2005
57
0.100
 Why?
Mutation
1
2018
1275
0.100
 Why?
Protein Binding
2
2005
648
0.100
 Why?
Immunity, Cellular
2
2003
68
0.100
 Why?
Mice, Nude
2
2004
247
0.100
 Why?
Lymphocyte Activation
3
2001
169
0.100
 Why?
C-Reactive Protein
1
2023
145
0.100
 Why?
Kinetics
2
2005
634
0.090
 Why?
Injections, Intramuscular
2
2003
49
0.090
 Why?
Interleukin-6
1
2023
261
0.090
 Why?
Binding Sites
2
2003
362
0.090
 Why?
Prognosis
3
2020
1974
0.090
 Why?
Tumor Necrosis Factor-alpha
1
2023
386
0.090
 Why?
Microscopy, Phase-Contrast
1
2010
13
0.090
 Why?
Lung
1
2014
493
0.090
 Why?
Body Weight
1
2023
517
0.090
 Why?
DNA Methylation
1
2015
548
0.090
 Why?
B-Lymphocytes
2
2002
171
0.090
 Why?
Transfection
3
2007
353
0.090
 Why?
Antigens, CD
2
2003
221
0.080
 Why?
Substrate Specificity
1
2010
190
0.080
 Why?
Membrane Glycoproteins
2
2003
246
0.080
 Why?
Actins
1
2010
112
0.080
 Why?
Dose-Response Relationship, Drug
2
2005
1369
0.080
 Why?
Antibodies, Catalytic
1
2009
1
0.080
 Why?
Receptors, CCR5
1
2009
6
0.080
 Why?
Neoplasm Invasiveness
1
2010
269
0.080
 Why?
Cells, Cultured
2
2003
1563
0.080
 Why?
Time Factors
2
2005
2933
0.080
 Why?
Killer Cells, Natural
1
2009
107
0.070
 Why?
Male
3
2023
25866
0.070
 Why?
Fucosyltransferases
1
2007
5
0.070
 Why?
Glycosaminoglycans
1
2007
19
0.070
 Why?
Molecular Biology
1
2007
23
0.070
 Why?
Binding Sites, Antibody
1
2006
16
0.070
 Why?
Rats
1
2023
3262
0.070
 Why?
Amino Acid Motifs
1
2006
55
0.070
 Why?
Cricetulus
1
2006
106
0.060
 Why?
Heparin
1
2007
91
0.060
 Why?
Antineoplastic Agents, Alkylating
1
2006
73
0.060
 Why?
Cell Membrane
1
2007
247
0.060
 Why?
E-Selectin
1
2005
14
0.060
 Why?
Xenograft Model Antitumor Assays
1
2006
210
0.060
 Why?
Cyclophosphamide
1
2006
168
0.060
 Why?
Hydrocarbons
1
2005
5
0.060
 Why?
Densitometry
1
2005
11
0.060
 Why?
Mannose
1
2005
16
0.060
 Why?
Wheat Germ Agglutinins
1
2005
3
0.060
 Why?
Methane
1
2005
9
0.060
 Why?
Surface Plasmon Resonance
1
2005
21
0.060
 Why?
Phosphorylcholine
1
2005
20
0.060
 Why?
Bone Marrow Cells
1
2006
195
0.060
 Why?
Growth Inhibitors
1
2005
26
0.060
 Why?
Biosensing Techniques
1
2005
25
0.060
 Why?
Genetic Variation
1
2006
197
0.060
 Why?
Calcium
1
2007
397
0.060
 Why?
Glycolysis
1
2005
69
0.060
 Why?
Immunoglobulins
1
2005
80
0.060
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
400
0.060
 Why?
Endothelial Cells
1
2006
256
0.060
 Why?
Antigen Presentation
1
2004
25
0.060
 Why?
Treatment Outcome
1
2014
5265
0.060
 Why?
Bone Neoplasms
1
2006
178
0.060
 Why?
Cytosol
1
2004
80
0.050
 Why?
Immunoglobulin Constant Regions
1
2003
3
0.050
 Why?
Plasmids
2
2003
159
0.050
 Why?
Recombinant Proteins
1
2005
477
0.050
 Why?
Middle Aged
2
2020
12579
0.050
 Why?
Histocompatibility Antigens Class II
1
2003
37
0.050
 Why?
Antibodies, Viral
1
2003
93
0.050
 Why?
Bacterial Capsules
1
2003
18
0.050
 Why?
Immunoglobulin M
1
2003
58
0.050
 Why?
DNA, Neoplasm
1
2003
144
0.050
 Why?
Th1 Cells
1
2003
52
0.050
 Why?
Carbohydrate Metabolism
1
2002
26
0.050
 Why?
Antibodies, Anti-Idiotypic
1
2002
24
0.050
 Why?
Models, Chemical
1
2002
64
0.050
 Why?
L-Selectin
1
2001
7
0.050
 Why?
Calorimetry
1
2001
6
0.050
 Why?
Carbohydrate Sequence
1
2001
10
0.050
 Why?
Epitope Mapping
1
2001
6
0.050
 Why?
Thermodynamics
1
2001
33
0.050
 Why?
Binding, Competitive
1
2001
93
0.050
 Why?
Gene Expression Profiling
1
2006
1020
0.050
 Why?
Mice, Inbred CBA
1
2001
35
0.050
 Why?
Protein Structure, Secondary
1
2001
71
0.050
 Why?
Sequence Homology, Amino Acid
1
2001
141
0.040
 Why?
Protein Conformation
1
2001
163
0.040
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
13
0.040
 Why?
Injections, Intraperitoneal
1
2000
59
0.040
 Why?
Colchicum
1
2020
3
0.040
 Why?
Inhibitory Concentration 50
1
2020
68
0.040
 Why?
Models, Molecular
1
2001
333
0.040
 Why?
Drug Screening Assays, Antitumor
1
2020
129
0.040
 Why?
Wnt Signaling Pathway
1
2020
85
0.040
 Why?
Child, Preschool
1
2008
3953
0.040
 Why?
H-2 Antigens
1
1999
3
0.040
 Why?
Receptors, Estrogen
1
2020
132
0.040
 Why?
Transformation, Genetic
1
1998
18
0.040
 Why?
Glycoside Hydrolases
1
1998
20
0.040
 Why?
Clostridium
1
1998
17
0.040
 Why?
Cell Survival
1
2020
587
0.040
 Why?
Plants
1
1998
26
0.040
 Why?
Genes, Reporter
1
1998
87
0.040
 Why?
Models, Biological
1
2001
717
0.040
 Why?
Survival Rate
1
2020
906
0.040
 Why?
Adolescent
1
2008
6453
0.030
 Why?
Retrospective Studies
1
2008
6274
0.030
 Why?
Child
1
2008
6931
0.030
 Why?
CpG Islands
1
2015
107
0.030
 Why?
Disease Progression
1
2015
825
0.020
 Why?
RNA, Small Interfering
1
2011
208
0.020
 Why?
RNA Interference
1
2011
179
0.020
 Why?
Lymphocyte Subsets
1
2003
14
0.010
 Why?
Simian virus 40
1
2003
14
0.010
 Why?
Immunoglobulin Variable Region
1
2003
15
0.010
 Why?
Mutagenesis, Site-Directed
1
2003
96
0.010
 Why?
Sequence Deletion
1
2003
66
0.010
 Why?
Protein Structure, Tertiary
1
2003
241
0.010
 Why?
Recombinant Fusion Proteins
1
2003
186
0.010
 Why?
Down-Regulation
1
2003
338
0.010
 Why?
Up-Regulation
1
2003
446
0.010
 Why?
Radiation Chimera
1
1999
3
0.010
 Why?
HIV Envelope Protein gp160
1
1999
2
0.010
 Why?
beta 2-Microglobulin
1
1999
37
0.010
 Why?
Protein Engineering
1
1999
17
0.010
 Why?
Plants, Toxic
1
1998
10
0.010
 Why?
Enzyme Stability
1
1998
20
0.010
 Why?
Plants, Genetically Modified
1
1998
18
0.010
 Why?
Stem Cells
1
1999
165
0.010
 Why?
Hot Temperature
1
1998
197
0.010
 Why?
Signal Transduction
1
2003
1608
0.010
 Why?
Mice, Knockout
1
1999
840
0.010
 Why?
Mice, Inbred C57BL
1
1999
1796
0.010
 Why?
Muscle, Skeletal
1
1999
786
0.010
 Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (272) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department